Structures by: Cruickshank D.
Total: 21
2,6-bis(pyrazol-1-yl)pyridine-4-carbothioamide
C12H10N6S
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 90-98
a=10.0603(4)Å b=11.0336(5)Å c=22.1907(8)Å
α=90.0000° β=90.0000° γ=90.0000°
Iron(II) bis(2,6-bis(pyrazol-1-yl)pyridine-4-carbothioamide) tetrafluorobroate
2(C12H10N6S)Fe,2(BF4),2(CH3NO2)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 90-98
a=51.880(2)Å b=8.4111(4)Å c=17.1533(8)Å
α=90.0000° β=94.245(7)° γ=90.0000°
Iron(II) bis(2,6-bis(pyrazol-1-yl)pyridine-4-carbothioamide) tetrafluorobroate
2(C12H10N6S)Fe,2(BF4),2(CH3NO2)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 90-98
a=51.605(2)Å b=8.3203(4)Å c=16.7867(7)Å
α=90.0000° β=93.676(7)° γ=90.0000°
Iron(II) bis(N-methyl-2,6-bis(pyrazol-1-yl)pyridine-4-carbothioamide ) tetrafluorobroate
C26H24FeN12S2,2(BF4),CH3NO2
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 90-98
a=8.25830(10)Å b=40.8625(4)Å c=10.80570(10)Å
α=90° β=94.7390(10)° γ=90°
2(C13H12N6S)Fe,2(ClO4)
2(C13H12N6S)Fe,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 90-98
a=8.2973(4)Å b=9.7480(4)Å c=20.6211(9)Å
α=81.087(7)° β=83.793(7)° γ=90.517(6)°
C26H24FeN12S2,2(ClO4)
C26H24FeN12S2,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 90-98
a=8.2808(2)Å b=10.2621(3)Å c=20.5898(5)Å
α=81.158(2)° β=86.276(2)° γ=89.446(2)°
N-methyl-2,6-bis(pyrazol-1-yl)pyridine-4-carbothioamide
C13H12N6S
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 90-98
a=6.4725(2)Å b=13.6562(5)Å c=31.8638(11)Å
α=90.0000° β=90.0000° γ=90.0000°
2(C13H12N6S)Fe,2(ClO4)
2(C13H12N6S)Fe,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 90-98
a=8.2899(3)Å b=9.9601(3)Å c=20.7440(6)Å
α=80.302(6)° β=83.941(6)° γ=89.321(6)°
2(C13H12N6S)Fe,2(BF4),CH3NO2
2(C13H12N6S)Fe,2(BF4),CH3NO2
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 90-98
a=8.2211(3)Å b=40.8700(18)Å c=10.7721(4)Å
α=90.0000° β=94.349(7)° γ=90.0000°
Octakis(2,3,6-tri-O-acetyl)-gamma-cyclodextrin.2(ethanol).H2O
(C96H128O64).2(C2H5OH).H2O
Chemical communications (Cambridge, England) (2007) 12 1221-1223
a=25.0841(1)Å b=25.0841(1)Å c=38.2760(2)Å
α=90.00° β=90.00° γ=90.00°
Octakis(2,3,6-tri-O-acetyl)-gamma-cyclodextrin sesqui(isopropanolate)monohydrate
C96H128O64.C4.5H12O1.5.H2O
Chemical communications (Cambridge, England) (2007) 12 1221-1223
a=25.0996(1)Å b=25.0996(1)Å c=38.1856(2)Å
α=90.00° β=90.00° γ=90.00°
1,2,4,5-tetrabromobenzene
C6H2Br4
Acta Crystallographica Section E (2018) 74, 5 613-619
a=3.9390(9)Å b=10.781(4)Å c=9.944(4)Å
α=90° β=100.49(3)° γ=90°
1,2,4,5-tetrabromobenzene
C6H2Br4
Acta Crystallographica Section E (2018) 74, 5 613-619
a=3.9390(9)Å b=10.781(4)Å c=9.944(4)Å
α=90° β=100.49(3)° γ=90°
1,2,4,5-tetrabromobenzene
C6H2Br4
Acta Crystallographica Section E (2018) 74, 5 613-619
a=3.9390(9)Å b=10.781(4)Å c=9.944(4)Å
α=90° β=100.49(3)° γ=90°
1,2,4,5-tetrabromobenzene
C6H2Br4
Acta Crystallographica Section E (2018) 74, 5 613-619
a=3.9431(5)Å b=10.7566(18)Å c=9.964(2)Å
α=90° β=100.557(15)° γ=90°
1,2,4,5-tetrabromobenzene
C6H2Br4
Acta Crystallographica Section E (2018) 74, 5 613-619
a=3.9431(5)Å b=10.7566(18)Å c=9.964(2)Å
α=90° β=100.557(15)° γ=90°
1,2,4,5-tetrabromobenzene
C6H2Br4
Acta Crystallographica Section E (2018) 74, 5 613-619
a=3.9431(5)Å b=10.7566(18)Å c=9.964(2)Å
α=90° β=100.557(15)° γ=90°
1,2,4,5-tetrabromobenzene
C6H2Br4
Acta Crystallographica Section E (2018) 74, 5 613-619
a=3.9431(5)Å b=10.7566(18)Å c=9.964(2)Å
α=90° β=100.557(15)° γ=90°
1,2,4,5-tetrabromobenzene
C6H2Br4
Acta Crystallographica Section E (2018) 74, 5 613-619
a=3.9431(5)Å b=10.7566(18)Å c=9.964(2)Å
α=90° β=100.557(15)° γ=90°
1,2,4,5-tetrabromobenzene
C6H2Br4
Acta Crystallographica Section E (2018) 74, 5 613-619
a=3.9431(5)Å b=10.7566(18)Å c=9.964(2)Å
α=90° β=100.557(15)° γ=90°
Iron(II) bis(N-methyl-2,6-bis(pyrazol-1-yl)pyridine-4-carbothioamide ) tetrafluorobroate
2(C13H12N6S)Fe,2(BF4),CH3NO2
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 90-98
a=8.0479(3)Å b=40.9514(14)Å c=10.6303(4)Å
α=90.0000° β=92.164(7)° γ=90.0000°